Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Brachytherapy × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 21 Uterine Cervical Neoplasms 13 Endometrial Neoplasms 4 Esophageal Neoplasms 3 Vaginal Neoplasms 2 Rhabdomyosarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Uveal Melanoma 1 Recurrent Head and Neck Carcinoma 1 Recurrence 1 Radiation Injuries 1 Prostatic Diseases 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Locally Advanced Cervical Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Clear Cell Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 2 atezolizumab 2 zenocutuzumab 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 entrectinib 1 cobimetinib 1 alectinib 1 Whole Genome Sequencing 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Specimen Handling 1 Sequence Analysis, RNA 1 Radiosurgery 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 HhAntag691 1 Genetic Testing 1 Genetic Profile 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Erlotinib Hydrochloride 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡